Role of ascorbate in protection by nitecapone against cardiac ischemia-reperfusion injury.

[1]  L. Packer,et al.  Effects of natural antioxidant ginkgo biloba extract (EGB 761) on myocardial ischemia-reperfusion injury. , 1994, Free radical biology & medicine.

[2]  M. Chevion,et al.  Copper and iron are mobilized following myocardial ischemia: possible predictive criteria for tissue injury. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[3]  L. Packer,et al.  Antioxidant properties of nitecapone (OR-462). , 1992, Free radical biology & medicine.

[4]  B. Giardina,et al.  Malondialdehyde production and ascorbate decrease are associated to the reperfusion of the isolated postischemic rat heart. , 1992, Free radical biology & medicine.

[5]  E. E. Dubinina,et al.  Molecular heterogeneity of plasma superoxide dismutase. , 1992, Free radical biology & medicine.

[6]  I. Yamazaki,et al.  EPR spin-trapping study on the oxidizing species formed in the reaction of the ferrous ion with hydrogen peroxide , 1991 .

[7]  A. Gordin,et al.  COMT inhibition with nitecapone does not affect the tyramine pressor response. , 1991, British journal of clinical pharmacology.

[8]  P Saltman,et al.  Cardiac reperfusion damage prevented by a nitroxide free radical. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[9]  E. Niki.  Vitamin C as an antioxidant. , 1991, World review of nutrition and dietetics.

[10]  M. Scheinin,et al.  Exercise hemodynamics and catecholamine metabolism after catechol‐O‐methyltransferase inhibition with nitecapone , 1990, Clinical pharmacology and therapeutics.

[11]  M. Levine,et al.  Determination of dehydroascorbic acid using high-performance liquid chromatography with coulometric electrochemical detection. , 1990, Analytical biochemistry.

[12]  L. Horwitz,et al.  Deferoxamine pretreatment reduces canine infarct size and oxidative injury. , 1990, The Journal of pharmacology and experimental therapeutics.

[13]  D. Ely,et al.  Decreased storage stability of creatine kinase in a cardiac reperfusion solution. , 1990, Clinical chemistry.

[14]  A. Arduini,et al.  Detection of ferryl myoglobin in the isolated ischemic rat heart. , 1990, Free radical biology & medicine.

[15]  R. Kloner,et al.  Deleterious Effects of Oxygen Radicals in Ischemia/Reperfusion Resolved and Unresolved Issues , 1989, Circulation.

[16]  D. Hearse,et al.  Free radicals and cardioplegia: organic anti-oxidants as additives to the St Thomas' Hospital cardioplegic solution. , 1989, Cardiovascular research.

[17]  S. Kaakkola,et al.  Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat. , 1988, European journal of pharmacology.

[18]  P. O’Neill,et al.  The iron chelator desferrioxamine attenuates postischemic ventricular dysfunction. , 1987, The American journal of physiology.

[19]  P. Menasche,et al.  Prevention of hydroxyl radical formation: a critical concept for improving cardioplegia. Protective effects of deferoxamine. , 1987, Circulation.

[20]  C. Tsao,et al.  Effect of dietary ascorbic acid intake on tissue vitamin C in mice. , 1987, The Journal of nutrition.

[21]  J. McCord,et al.  Oxygen-derived free radicals in postischemic tissue injury. , 1985, The New England journal of medicine.

[22]  J. Packer,et al.  Direct observation of a free radical interaction between vitamin E and vitamin C , 1979, Nature.

[23]  L. Stookey.  Ferrozine---a new spectrophotometric reagent for iron , 1970 .

[24]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.